Sign in
Taking people in United StatesNo phase

Therapy for Cancer Distress and Quality of Life After Treatment for Advanced Melanoma

Tests talk therapy for cancer-related distress in adults treated for advanced melanoma.

Key facts

Who runs it
Mayo Clinic
Where
Rochester, United StatesSee the site
Trial code
Registry title
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
Status
Recruiting
People taking part
350 people, planned
Started
10 Dec 2025
Expected to end
31 Dec 2031
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Best Practice
  • Cognitive Behavior Therapy
  • Electronic Health Record Review
  • Questionnaire Administration
Record updated
22 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with newly diagnosed stage III-IV melanoma. It studies quality of life and mental health after treatment, and whether cognitive behavioral therapy for cancer distress (CBT-C) helps.

Age
18 years or older
Sex
All sexes can join
Disease stage
Stage III-IV melanoma, diagnosed 2 months ago or less

Main reasons for not taking part

  • Not able to read English well enough to complete the survey and informed consent
  • Does not meet the inclusion criteria

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Age >= 18-years
  • Stage III-IV melanoma and =< 2 month duration of this diagnosis
  • Able to read English sufficient to complete survey, informed consent

Who cannot take part

  • Does not meet inclusion criteria

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesContact: Clinical Trials Referral OfficeTaking people

About the trial

What the trial wants to find out

This clinical trial studies how people feel and live during the first two years after being treated for melanoma and whether cognitive behavioral therapy for cancer distress (CBT-C) works to improve quality of life in patients with stage III-IV melanoma. The melanoma survivorship population is rapidly growing, given the increasing survival rates due to treatment advancements. An urgent need to better define and optimize comprehensive quality of life inclusive of mental health (QOL-MH) has been identified. Cognitive behavioral therapy is a type of psychotherapy that helps patients change their behavior by changing the way they think and feel about certain things. CBT-C is a new type of care that helps patients cope with cancer-related stress, which can include problems like trouble sleeping, trouble focusing, or changes in social life and daily activities. Gathering information on how melanoma patients feel and live during the first two years after treatment may help promote improved care and continued scientific advancements in the understanding of melanoma specific QOL-MH and survivorship as a whole, and may also help determine whether CBT-C improves qualify of life in patients with stage III-IV melanoma.

The 3 groups in the trial

  • Aim 1 (QOL-MH)Treatment being tested

    Patients complete QOL-MH questionnaires at baseline and 3, 6, 9, 12, 18, and 24-months post-stage III-IV diagnosis. Patients living in Minnesota, Iowa, or Wisconsin may also optionally participate in aim 2.

    Treatment: Electronic Health Record Review and Questionnaire Administration

  • Aim 2 arm I (CBT-C)Treatment being tested

    Patients attend CBT-C sessions once a week for 6 weeks in the absence of unacceptable toxicity.

    Treatment: Cognitive Behavior Therapy, Electronic Health Record Review, and Questionnaire Administration

  • Aim 2 arm II (SOC)Existing treatment, for comparison

    Patients receive SOC for 6 weeks in the absence of unacceptable toxicity.

    Treatment: Best Practice, Electronic Health Record Review, and Questionnaire Administration

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Launching the Era of Melanoma Survivorship: Defining Benchmarks in Quality of Life Inclusive of Mental Health (QOL-MH)
Plain-language title
Therapy for Cancer Distress and Quality of Life After Treatment for Advanced MelanomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
22 June 2026